First Page | Document Content | |
---|---|---|
Date: 2016-07-02 14:50:25Health Medicine Breakthrough therapy Specialty drugs Gilead Sciences Healthcare-associated infections Cyclopropanes Sofosbuvir Ledipasvir National Institute for Health and Care Excellence Hepatitis National Health Service | Microsoft Word - GILEAD BRIEFINGAdd to Reading ListSource URL: www.ukts.orgDownload Document from Source WebsiteFile Size: 102,77 KBShare Document on Facebook |